Home Arena - Flatness In Scripts Will Impact The Equity
 

Keywords :   


Arena - Flatness In Scripts Will Impact The Equity

2015-05-09 04:01:10| Biotech - Topix.net

Arena Pharmaceuticals has seen sales of the anti-obesity drug Belviq flatten out over the past few weeks while competitor Contrave from Orexigen continues to close the gap. Over the last two months Belviq sales have gained less than 1% and have moved from about 14,100 scripts in the first week in March to about 14,800 scripts at the close of April.

Tags: the impact equity scripts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.11SHODO-X 12 7
28.11 CT 300MG RIGHT() 24
28.11Coleman
28.11CD / 88cm CDS
28.11PSA10 e
28.11YAMAHA
28.11PSA 10 HOLW91055
28.11nima
More »